HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2- ((1- (3,5- dichlorobenzenesulfonyl)pyrrolidine- 2- carbonyl)amino)- 4- (4- methyl- 2- (methyl- (2- (4- (3- o- tolylureido)phenyl)acetyl)amino)pentanoylamino)butyric acid

an integrin alpha4beta1 inhibitor; structure in first source
Also Known As:
BIO 5192; BIO-5192; BIO5192
Networked: 4 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Leone, D R: 2 articles (02/2005 - 06/2003)
2. Pepinsky, R B: 2 articles (02/2005 - 06/2003)
3. Petter, R C: 2 articles (02/2005 - 06/2003)
4. Giza, K: 2 articles (02/2005 - 06/2003)
5. Lee, W-C: 2 articles (02/2005 - 06/2003)
6. Nickerson-Nutter, C: 2 articles (02/2005 - 06/2003)
7. Cornebise, M: 2 articles (02/2005 - 06/2003)
8. Dolinski, B M: 2 articles (02/2005 - 06/2003)
9. Perper, S: 2 articles (02/2005 - 06/2003)
10. Adams, S P: 2 articles (02/2005 - 06/2003)

Related Diseases

1. Acute Disease
2. Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
3. Disease Progression
4. Multiple Sclerosis
5. Hyperalgesia

Related Drugs and Biologics

1. Integrin alpha4beta1 (VLA-4)
2. Butyric Acid (Butanoic Acid)
3. pyrrolidine